Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor necrosis factor.

L J Old

    Scientific American
    |May 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Bacterial infections can trigger cancer regression by stimulating tumor necrosis factor (TNF), a protein with anticancer properties. This discovery has led to TNF being investigated as a potential cancer treatment.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    T cell assays and MIATA: the essential minimum for maximum impact.

    Immunity·2012
    Same author

    Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase.

    British journal of cancer·2011
    Same author

    Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond.

    Cancer immunology, immunotherapy : CII·2010
    Same author

    Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.

    British journal of cancer·2006
    Same author

    Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.

    Preparative biochemistry & biotechnology·2005
    Same author

    Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.

    British journal of cancer·2005
    Same journal

    50, 100 & 150 Years: Natural fission reactor uncovered; geometry of soap bubbles.

    Scientific American·2026
    Same journal

    Academic Freedom in Decline: When scientists can't research what they want, innovation suffers.

    Scientific American·2026
    Same journal

    Robots Can Now Fold Your Laundry: Home-helper tasks are becoming easier for robotic assistants.

    Scientific American·2026
    Same journal

    Journey to Titan: Inside NASA's Dragonfly mission to Saturn's largest moon.

    Scientific American·2026
    Same journal

    Getting Pesticides Off Fruits and Veggies: Using more than water to wash produce can clean pesticide residues.

    Scientific American·2026
    Same journal

    How Probability Theory Got Its Start: Disagreement over how to divvy up the pot in an interrupted game of chance led early mathematicians to invent modern risk assessment.

    Scientific American·2026
    See all related articles

    Area of Science:

    • Oncology
    • Immunology
    • Microbiology

    Background:

    • Historical observations noted spontaneous cancer regression following bacterial infections.
    • Early research suggested an immune-mediated mechanism for tumor regression.

    Observation:

    • A 1975 study identified tumor necrosis factor (TNF) as the key mediator stimulated by bacterial infections.
    • TNF was found to possess direct anticancer activity.

    Findings:

    • Bacterial infections can induce cancer regression through the stimulation of TNF.
    • TNF plays a crucial role in regulating inflammation and immune responses.
    • Current clinical trials are evaluating TNF as a therapeutic agent for cancer.

    Implications:

    • This research highlights the potential of harnessing the immune system and specific molecular pathways for cancer therapy.
    • The findings pave the way for novel immunotherapies and targeted drug development in oncology.
    • Further investigation into TNF's mechanisms could lead to more effective cancer treatments.